- Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapyPamela A Moise-Broder
School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY, USA
Clin Infect Dis 38:1700-5. 2004..aureus clones with this genetic marker under vancomycin selective pressure...
- Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaGeorge Sakoulas
Crystal Run Healthcare, 155 Crystal Run Rd, Middletown, NY 10941, USA
J Clin Microbiol 42:2398-402. 2004..Prognostic information for vancomycin treatment outcome in MRSA bacteremia may also be obtained by testing the in vitro bactericidal potency of vancomycin...
- Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infectionsPamela A Moise-Broder
CPL Associates, LLC, Amherst, New York, USA
Clin Pharmacokinet 43:925-42. 2004....